Clinical Trials Browser

Phase 2 × Neoplasms × decitabine and cedazuridine drug combination × Clear all

NCT06351306 2025-03-24

DEC-C and Thioguanine for R/R AML

Phase 2 Withdrawn

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute